Emergency medical service provider GMR Solutions (GMRS.US) will debut on the New York Stock Exchange tonight, with the IPO size reduced by 36% to $479 million.
Leading provider of emergency medical and alternative site medical services in the United States, GMR Solutions, Tuesday, Eastern time, reduced the proposed size of its upcoming initial public offering (IPO).
Leading provider of emergency medical and alternative site medical services in the United States, GMR Solutions (GMRS.US) announced on Tuesday that it has lowered the planned offering size of its upcoming initial public offering (IPO). The company is set to debut on the New York Stock Exchange on May 13th and is planning to issue 31.9 million shares at $15 per share, raising $479 million. Previously, the company had planned to issue the same number of shares at a price range of $22 to $25 per share. Based on the adjusted midpoint of the range, GMR Solutions' fundraising amount will decrease by 36% from previous expectations, with a fully diluted market value of approximately $3.8 billion, a 31% decrease from the previous terms.
Established in 2018 and headquartered in Lewisville, Texas, GMR Solutions was formed through the merger of Air Medical Group Holdings and American Medical Response. It is a provider of emergency medical services and outpatient care in the U.S. and international markets. The company offers on-site clinical care through a skilled medical team and coordinates air and ground ambulance transportation for patients who require higher levels of care, as well as directing non-emergency patients to less critical care facilities. Its business covers a wide range of urban and rural community networks, acting as an entry point to the healthcare system and supporting the delivery of medical services in various emergency and non-emergency situations.
In the twelve months ending on December 31, 2025, GMR Solutions had revenues of $5.7 billion. The joint bookrunners for this offering are JPMorgan, KKR, BofA Securities, Barclays, Goldman Sachs Group, Inc., Citigroup, Evercore ISI, Morgan Stanley, and UBS Group AG.
Related Articles

POP MART (09992) will distribute a final dividend of 2.3817 yuan per share on May 28th.

V&V TECH (08113) recommends increasing the authorized capital to 60 million Hong Kong dollars.

On May 13, Simcere Pharma (02096) spent 12.2958 million Hong Kong dollars to repurchase 1.063 million shares.
POP MART (09992) will distribute a final dividend of 2.3817 yuan per share on May 28th.

V&V TECH (08113) recommends increasing the authorized capital to 60 million Hong Kong dollars.

On May 13, Simcere Pharma (02096) spent 12.2958 million Hong Kong dollars to repurchase 1.063 million shares.

RECOMMEND

Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026

HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026

The Chip Stock Frenzy Is Still Accelerating
11/05/2026


